Global Neuropathic Pain Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neuropathic Pain Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuropathic Pain Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuropathic Pain Therapeutics market. Neuropathic Pain Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuropathic Pain Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuropathic Pain Therapeutics market.
Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neuropathic Pain Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuropathic Pain Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anticonvulsants, Antidepressants), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuropathic Pain Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuropathic Pain Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuropathic Pain Therapeutics industry. This include advancements in Neuropathic Pain Therapeutics technology, Neuropathic Pain Therapeutics new entrants, Neuropathic Pain Therapeutics new investment, and other innovations that are shaping the future of Neuropathic Pain Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuropathic Pain Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Neuropathic Pain Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuropathic Pain Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuropathic Pain Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuropathic Pain Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuropathic Pain Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuropathic Pain Therapeutics market.
Market Segmentation:
Neuropathic Pain Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neuropathic Pain Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuropathic Pain Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuropathic Pain Therapeutics market. Neuropathic Pain Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuropathic Pain Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuropathic Pain Therapeutics market.
Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neuropathic Pain Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuropathic Pain Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anticonvulsants, Antidepressants), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuropathic Pain Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuropathic Pain Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuropathic Pain Therapeutics industry. This include advancements in Neuropathic Pain Therapeutics technology, Neuropathic Pain Therapeutics new entrants, Neuropathic Pain Therapeutics new investment, and other innovations that are shaping the future of Neuropathic Pain Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuropathic Pain Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Neuropathic Pain Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuropathic Pain Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuropathic Pain Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuropathic Pain Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuropathic Pain Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuropathic Pain Therapeutics market.
Market Segmentation:
Neuropathic Pain Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Anticonvulsants
- Antidepressants
- NSAIDs
- Opioids
- Steroids
- Others
- Diabetic Neuropathy
- Chemotherapy-Induced Neuropathy Pain
- Postherpetic Neuralgia
- Spinal Cord Injury
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis AG
- AstraZeneca
- GlaxoSmithKline
- Eli Lilly and Company
- Mallinckrodt Pharmaceuticals
- Johnson & Johnson
- Abbott
- Endo Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Limited
- Merck & Co
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuropathic Pain Therapeutics Market Size 2019-2030
2.1.2 Neuropathic Pain Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuropathic Pain Therapeutics Segment by Type
2.2.1 Anticonvulsants
2.2.2 Antidepressants
2.2.3 NSAIDs
2.2.4 Opioids
2.2.5 Steroids
2.2.6 Others
2.3 Neuropathic Pain Therapeutics Market Size by Type
2.3.1 Neuropathic Pain Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Neuropathic Pain Therapeutics Segment by Application
2.4.1 Diabetic Neuropathy
2.4.2 Chemotherapy-Induced Neuropathy Pain
2.4.3 Postherpetic Neuralgia
2.4.4 Spinal Cord Injury
2.4.5 Others
2.5 Neuropathic Pain Therapeutics Market Size by Application
2.5.1 Neuropathic Pain Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
3 NEUROPATHIC PAIN THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Neuropathic Pain Therapeutics Market Size Market Share by Players
3.1.1 Global Neuropathic Pain Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neuropathic Pain Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROPATHIC PAIN THERAPEUTICS BY REGIONS
4.1 Neuropathic Pain Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.3 APAC Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.4 Europe Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuropathic Pain Therapeutics Market Size by Country (2019-2024)
5.2 Americas Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
5.3 Americas Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuropathic Pain Therapeutics Market Size by Region (2019-2024)
6.2 APAC Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
6.3 APAC Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuropathic Pain Therapeutics by Country (2019-2024)
7.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
7.3 Europe Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuropathic Pain Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROPATHIC PAIN THERAPEUTICS MARKET FORECAST
10.1 Global Neuropathic Pain Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Neuropathic Pain Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Neuropathic Pain Therapeutics Forecast
10.1.3 APAC Neuropathic Pain Therapeutics Forecast
10.1.4 Europe Neuropathic Pain Therapeutics Forecast
10.1.5 Middle East & Africa Neuropathic Pain Therapeutics Forecast
10.2 Americas Neuropathic Pain Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Neuropathic Pain Therapeutics Market Forecast
10.2.2 Canada Neuropathic Pain Therapeutics Market Forecast
10.2.3 Mexico Neuropathic Pain Therapeutics Market Forecast
10.2.4 Brazil Neuropathic Pain Therapeutics Market Forecast
10.3 APAC Neuropathic Pain Therapeutics Forecast by Region (2025-2030)
10.3.1 China Neuropathic Pain Therapeutics Market Forecast
10.3.2 Japan Neuropathic Pain Therapeutics Market Forecast
10.3.3 Korea Neuropathic Pain Therapeutics Market Forecast
10.3.4 Southeast Asia Neuropathic Pain Therapeutics Market Forecast
10.3.5 India Neuropathic Pain Therapeutics Market Forecast
10.3.6 Australia Neuropathic Pain Therapeutics Market Forecast
10.4 Europe Neuropathic Pain Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Neuropathic Pain Therapeutics Market Forecast
10.4.2 France Neuropathic Pain Therapeutics Market Forecast
10.4.3 UK Neuropathic Pain Therapeutics Market Forecast
10.4.4 Italy Neuropathic Pain Therapeutics Market Forecast
10.4.5 Russia Neuropathic Pain Therapeutics Market Forecast
10.5 Middle East & Africa Neuropathic Pain Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Neuropathic Pain Therapeutics Market Forecast
10.5.2 South Africa Neuropathic Pain Therapeutics Market Forecast
10.5.3 Israel Neuropathic Pain Therapeutics Market Forecast
10.5.4 Turkey Neuropathic Pain Therapeutics Market Forecast
10.5.5 GCC Countries Neuropathic Pain Therapeutics Market Forecast
10.6 Global Neuropathic Pain Therapeutics Forecast by Type (2025-2030)
10.7 Global Neuropathic Pain Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuropathic Pain Therapeutics Product Offered
11.1.3 Pfizer Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Neuropathic Pain Therapeutics Product Offered
11.2.3 Novartis AG Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Neuropathic Pain Therapeutics Product Offered
11.3.3 AstraZeneca Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Neuropathic Pain Therapeutics Product Offered
11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Neuropathic Pain Therapeutics Product Offered
11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly and Company Main Business Overview
11.5.5 Eli Lilly and Company Latest Developments
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Information
11.6.2 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offered
11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mallinckrodt Pharmaceuticals Main Business Overview
11.6.5 Mallinckrodt Pharmaceuticals Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Neuropathic Pain Therapeutics Product Offered
11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Neuropathic Pain Therapeutics Product Offered
11.8.3 Abbott Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Endo Pharmaceuticals, Inc.
11.9.1 Endo Pharmaceuticals, Inc. Company Information
11.9.2 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offered
11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Endo Pharmaceuticals, Inc. Main Business Overview
11.9.5 Endo Pharmaceuticals, Inc. Latest Developments
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Information
11.10.2 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offered
11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Teva Pharmaceutical Industries Limited Main Business Overview
11.10.5 Teva Pharmaceutical Industries Limited Latest Developments
11.11 Merck & Co
11.11.1 Merck & Co Company Information
11.11.2 Merck & Co Neuropathic Pain Therapeutics Product Offered
11.11.3 Merck & Co Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck & Co Main Business Overview
11.11.5 Merck & Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuropathic Pain Therapeutics Market Size 2019-2030
2.1.2 Neuropathic Pain Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuropathic Pain Therapeutics Segment by Type
2.2.1 Anticonvulsants
2.2.2 Antidepressants
2.2.3 NSAIDs
2.2.4 Opioids
2.2.5 Steroids
2.2.6 Others
2.3 Neuropathic Pain Therapeutics Market Size by Type
2.3.1 Neuropathic Pain Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Neuropathic Pain Therapeutics Segment by Application
2.4.1 Diabetic Neuropathy
2.4.2 Chemotherapy-Induced Neuropathy Pain
2.4.3 Postherpetic Neuralgia
2.4.4 Spinal Cord Injury
2.4.5 Others
2.5 Neuropathic Pain Therapeutics Market Size by Application
2.5.1 Neuropathic Pain Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
3 NEUROPATHIC PAIN THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Neuropathic Pain Therapeutics Market Size Market Share by Players
3.1.1 Global Neuropathic Pain Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neuropathic Pain Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROPATHIC PAIN THERAPEUTICS BY REGIONS
4.1 Neuropathic Pain Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.3 APAC Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.4 Europe Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuropathic Pain Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuropathic Pain Therapeutics Market Size by Country (2019-2024)
5.2 Americas Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
5.3 Americas Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuropathic Pain Therapeutics Market Size by Region (2019-2024)
6.2 APAC Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
6.3 APAC Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuropathic Pain Therapeutics by Country (2019-2024)
7.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
7.3 Europe Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuropathic Pain Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROPATHIC PAIN THERAPEUTICS MARKET FORECAST
10.1 Global Neuropathic Pain Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Neuropathic Pain Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Neuropathic Pain Therapeutics Forecast
10.1.3 APAC Neuropathic Pain Therapeutics Forecast
10.1.4 Europe Neuropathic Pain Therapeutics Forecast
10.1.5 Middle East & Africa Neuropathic Pain Therapeutics Forecast
10.2 Americas Neuropathic Pain Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Neuropathic Pain Therapeutics Market Forecast
10.2.2 Canada Neuropathic Pain Therapeutics Market Forecast
10.2.3 Mexico Neuropathic Pain Therapeutics Market Forecast
10.2.4 Brazil Neuropathic Pain Therapeutics Market Forecast
10.3 APAC Neuropathic Pain Therapeutics Forecast by Region (2025-2030)
10.3.1 China Neuropathic Pain Therapeutics Market Forecast
10.3.2 Japan Neuropathic Pain Therapeutics Market Forecast
10.3.3 Korea Neuropathic Pain Therapeutics Market Forecast
10.3.4 Southeast Asia Neuropathic Pain Therapeutics Market Forecast
10.3.5 India Neuropathic Pain Therapeutics Market Forecast
10.3.6 Australia Neuropathic Pain Therapeutics Market Forecast
10.4 Europe Neuropathic Pain Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Neuropathic Pain Therapeutics Market Forecast
10.4.2 France Neuropathic Pain Therapeutics Market Forecast
10.4.3 UK Neuropathic Pain Therapeutics Market Forecast
10.4.4 Italy Neuropathic Pain Therapeutics Market Forecast
10.4.5 Russia Neuropathic Pain Therapeutics Market Forecast
10.5 Middle East & Africa Neuropathic Pain Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Neuropathic Pain Therapeutics Market Forecast
10.5.2 South Africa Neuropathic Pain Therapeutics Market Forecast
10.5.3 Israel Neuropathic Pain Therapeutics Market Forecast
10.5.4 Turkey Neuropathic Pain Therapeutics Market Forecast
10.5.5 GCC Countries Neuropathic Pain Therapeutics Market Forecast
10.6 Global Neuropathic Pain Therapeutics Forecast by Type (2025-2030)
10.7 Global Neuropathic Pain Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuropathic Pain Therapeutics Product Offered
11.1.3 Pfizer Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Neuropathic Pain Therapeutics Product Offered
11.2.3 Novartis AG Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis AG Main Business Overview
11.2.5 Novartis AG Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Neuropathic Pain Therapeutics Product Offered
11.3.3 AstraZeneca Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Neuropathic Pain Therapeutics Product Offered
11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Neuropathic Pain Therapeutics Product Offered
11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eli Lilly and Company Main Business Overview
11.5.5 Eli Lilly and Company Latest Developments
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Information
11.6.2 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offered
11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mallinckrodt Pharmaceuticals Main Business Overview
11.6.5 Mallinckrodt Pharmaceuticals Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Neuropathic Pain Therapeutics Product Offered
11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Neuropathic Pain Therapeutics Product Offered
11.8.3 Abbott Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Endo Pharmaceuticals, Inc.
11.9.1 Endo Pharmaceuticals, Inc. Company Information
11.9.2 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offered
11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Endo Pharmaceuticals, Inc. Main Business Overview
11.9.5 Endo Pharmaceuticals, Inc. Latest Developments
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Information
11.10.2 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offered
11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Teva Pharmaceutical Industries Limited Main Business Overview
11.10.5 Teva Pharmaceutical Industries Limited Latest Developments
11.11 Merck & Co
11.11.1 Merck & Co Company Information
11.11.2 Merck & Co Neuropathic Pain Therapeutics Product Offered
11.11.3 Merck & Co Neuropathic Pain Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck & Co Main Business Overview
11.11.5 Merck & Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuropathic Pain Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anticonvulsants
Table 3. Major Players of Antidepressants
Table 4. Major Players of NSAIDs
Table 5. Major Players of Opioids
Table 6. Major Players of Steroids
Table 7. Major Players of Others
Table 8. Neuropathic Pain Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 11. Neuropathic Pain Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 14. Global Neuropathic Pain Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Neuropathic Pain Therapeutics Revenue Market Share by Player (2019-2024)
Table 16. Neuropathic Pain Therapeutics Key Players Head office and Products Offered
Table 17. Neuropathic Pain Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neuropathic Pain Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Neuropathic Pain Therapeutics Market Size Market Share by Regions (2019-2024)
Table 22. Global Neuropathic Pain Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Neuropathic Pain Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Neuropathic Pain Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Neuropathic Pain Therapeutics Market Size Market Share by Country (2019-2024)
Table 26. Americas Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 28. Americas Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 30. APAC Neuropathic Pain Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Table 32. APAC Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 34. APAC Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 36. Europe Neuropathic Pain Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Neuropathic Pain Therapeutics Market Size Market Share by Country (2019-2024)
Table 38. Europe Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 40. Europe Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Neuropathic Pain Therapeutics
Table 49. Key Market Challenges & Risks of Neuropathic Pain Therapeutics
Table 50. Key Industry Trends of Neuropathic Pain Therapeutics
Table 51. Global Neuropathic Pain Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Neuropathic Pain Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Neuropathic Pain Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Pfizer Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 56. Pfizer Neuropathic Pain Therapeutics Product Offered
Table 57. Pfizer Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Novartis AG Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 61. Novartis AG Neuropathic Pain Therapeutics Product Offered
Table 62. Novartis AG Main Business
Table 63. Novartis AG Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Novartis AG Latest Developments
Table 65. AstraZeneca Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 66. AstraZeneca Neuropathic Pain Therapeutics Product Offered
Table 67. AstraZeneca Main Business
Table 68. AstraZeneca Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. AstraZeneca Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 71. GlaxoSmithKline Neuropathic Pain Therapeutics Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Eli Lilly and Company Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 76. Eli Lilly and Company Neuropathic Pain Therapeutics Product Offered
Table 77. Eli Lilly and Company Main Business
Table 78. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Eli Lilly and Company Latest Developments
Table 80. Mallinckrodt Pharmaceuticals Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 81. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offered
Table 82. Mallinckrodt Pharmaceuticals Main Business
Table 83. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Mallinckrodt Pharmaceuticals Latest Developments
Table 85. Johnson & Johnson Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 86. Johnson & Johnson Neuropathic Pain Therapeutics Product Offered
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Johnson & Johnson Latest Developments
Table 90. Abbott Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 91. Abbott Neuropathic Pain Therapeutics Product Offered
Table 92. Abbott Main Business
Table 93. Abbott Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Abbott Latest Developments
Table 95. Endo Pharmaceuticals, Inc. Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 96. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offered
Table 97. Endo Pharmaceuticals, Inc. Main Business
Table 98. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Endo Pharmaceuticals, Inc. Latest Developments
Table 100. Teva Pharmaceutical Industries Limited Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 101. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offered
Table 102. Teva Pharmaceutical Industries Limited Main Business
Table 103. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Teva Pharmaceutical Industries Limited Latest Developments
Table 105. Merck & Co Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 106. Merck & Co Neuropathic Pain Therapeutics Product Offered
Table 107. Merck & Co Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Merck & Co Main Business
Table 109. Merck & Co Latest Developments
Table 1. Neuropathic Pain Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anticonvulsants
Table 3. Major Players of Antidepressants
Table 4. Major Players of NSAIDs
Table 5. Major Players of Opioids
Table 6. Major Players of Steroids
Table 7. Major Players of Others
Table 8. Neuropathic Pain Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 11. Neuropathic Pain Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 14. Global Neuropathic Pain Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Neuropathic Pain Therapeutics Revenue Market Share by Player (2019-2024)
Table 16. Neuropathic Pain Therapeutics Key Players Head office and Products Offered
Table 17. Neuropathic Pain Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Neuropathic Pain Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Neuropathic Pain Therapeutics Market Size Market Share by Regions (2019-2024)
Table 22. Global Neuropathic Pain Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Neuropathic Pain Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Neuropathic Pain Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Neuropathic Pain Therapeutics Market Size Market Share by Country (2019-2024)
Table 26. Americas Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 28. Americas Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 30. APAC Neuropathic Pain Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Table 32. APAC Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 34. APAC Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 36. Europe Neuropathic Pain Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Neuropathic Pain Therapeutics Market Size Market Share by Country (2019-2024)
Table 38. Europe Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 40. Europe Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Neuropathic Pain Therapeutics
Table 49. Key Market Challenges & Risks of Neuropathic Pain Therapeutics
Table 50. Key Industry Trends of Neuropathic Pain Therapeutics
Table 51. Global Neuropathic Pain Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Neuropathic Pain Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Neuropathic Pain Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Pfizer Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 56. Pfizer Neuropathic Pain Therapeutics Product Offered
Table 57. Pfizer Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Novartis AG Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 61. Novartis AG Neuropathic Pain Therapeutics Product Offered
Table 62. Novartis AG Main Business
Table 63. Novartis AG Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Novartis AG Latest Developments
Table 65. AstraZeneca Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 66. AstraZeneca Neuropathic Pain Therapeutics Product Offered
Table 67. AstraZeneca Main Business
Table 68. AstraZeneca Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. AstraZeneca Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 71. GlaxoSmithKline Neuropathic Pain Therapeutics Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Eli Lilly and Company Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 76. Eli Lilly and Company Neuropathic Pain Therapeutics Product Offered
Table 77. Eli Lilly and Company Main Business
Table 78. Eli Lilly and Company Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Eli Lilly and Company Latest Developments
Table 80. Mallinckrodt Pharmaceuticals Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 81. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product Offered
Table 82. Mallinckrodt Pharmaceuticals Main Business
Table 83. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Mallinckrodt Pharmaceuticals Latest Developments
Table 85. Johnson & Johnson Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 86. Johnson & Johnson Neuropathic Pain Therapeutics Product Offered
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Johnson & Johnson Latest Developments
Table 90. Abbott Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 91. Abbott Neuropathic Pain Therapeutics Product Offered
Table 92. Abbott Main Business
Table 93. Abbott Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Abbott Latest Developments
Table 95. Endo Pharmaceuticals, Inc. Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 96. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product Offered
Table 97. Endo Pharmaceuticals, Inc. Main Business
Table 98. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Endo Pharmaceuticals, Inc. Latest Developments
Table 100. Teva Pharmaceutical Industries Limited Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 101. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product Offered
Table 102. Teva Pharmaceutical Industries Limited Main Business
Table 103. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Teva Pharmaceutical Industries Limited Latest Developments
Table 105. Merck & Co Details, Company Type, Neuropathic Pain Therapeutics Area Served and Its Competitors
Table 106. Merck & Co Neuropathic Pain Therapeutics Product Offered
Table 107. Merck & Co Neuropathic Pain Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Merck & Co Main Business
Table 109. Merck & Co Latest Developments
LIST OF FIGURES
Figure 1. Neuropathic Pain Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuropathic Pain Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuropathic Pain Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuropathic Pain Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Neuropathic Pain Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuropathic Pain Therapeutics Market Size Market Share by Type in 2023
Figure 10. Neuropathic Pain Therapeutics in Diabetic Neuropathy
Figure 11. Global Neuropathic Pain Therapeutics Market: Diabetic Neuropathy (2019-2024) & ($ Millions)
Figure 12. Neuropathic Pain Therapeutics in Chemotherapy-Induced Neuropathy Pain
Figure 13. Global Neuropathic Pain Therapeutics Market: Chemotherapy-Induced Neuropathy Pain (2019-2024) & ($ Millions)
Figure 14. Neuropathic Pain Therapeutics in Postherpetic Neuralgia
Figure 15. Global Neuropathic Pain Therapeutics Market: Postherpetic Neuralgia (2019-2024) & ($ Millions)
Figure 16. Neuropathic Pain Therapeutics in Spinal Cord Injury
Figure 17. Global Neuropathic Pain Therapeutics Market: Spinal Cord Injury (2019-2024) & ($ Millions)
Figure 18. Neuropathic Pain Therapeutics in Others
Figure 19. Global Neuropathic Pain Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Neuropathic Pain Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Neuropathic Pain Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Neuropathic Pain Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Neuropathic Pain Therapeutics Value Market Share by Country in 2023
Figure 28. United States Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Neuropathic Pain Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Neuropathic Pain Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Neuropathic Pain Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Neuropathic Pain Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neuropathic Pain Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuropathic Pain Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuropathic Pain Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuropathic Pain Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Neuropathic Pain Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuropathic Pain Therapeutics Market Size Market Share by Type in 2023
Figure 10. Neuropathic Pain Therapeutics in Diabetic Neuropathy
Figure 11. Global Neuropathic Pain Therapeutics Market: Diabetic Neuropathy (2019-2024) & ($ Millions)
Figure 12. Neuropathic Pain Therapeutics in Chemotherapy-Induced Neuropathy Pain
Figure 13. Global Neuropathic Pain Therapeutics Market: Chemotherapy-Induced Neuropathy Pain (2019-2024) & ($ Millions)
Figure 14. Neuropathic Pain Therapeutics in Postherpetic Neuralgia
Figure 15. Global Neuropathic Pain Therapeutics Market: Postherpetic Neuralgia (2019-2024) & ($ Millions)
Figure 16. Neuropathic Pain Therapeutics in Spinal Cord Injury
Figure 17. Global Neuropathic Pain Therapeutics Market: Spinal Cord Injury (2019-2024) & ($ Millions)
Figure 18. Neuropathic Pain Therapeutics in Others
Figure 19. Global Neuropathic Pain Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Neuropathic Pain Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Neuropathic Pain Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Neuropathic Pain Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Neuropathic Pain Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Neuropathic Pain Therapeutics Value Market Share by Country in 2023
Figure 28. United States Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Neuropathic Pain Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Neuropathic Pain Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Neuropathic Pain Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Neuropathic Pain Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Neuropathic Pain Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Neuropathic Pain Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Neuropathic Pain Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Neuropathic Pain Therapeutics Market Size Market Share Forecast by Application (2025-2030)
